FDA Announces The Establishment Of The OCE Equity Program (Catapult's regulatory round-up - May 2024)
FDA Oncology Center of Excellence (OCE) announced the formation of The OCE Equity Program to improve access to clinical trials of oncology medical products for populations that have been historically underrepresented in clinical research, such as racial and ethnic minorities, individuals who live in rural areas, sexual and gender minorities, and individuals with economic, linguistic, or cultural barriers to healthcare services. The OCE Equity Program seeks to advance equitable access to clin...
Publication Details
- Journal
- Industrias Culturais (Universidade de Coimbra)
- Published
- 2024-11-04
- DOI
- https://doi.org/10.58079/12m7c
- Primary Topic
- Biomedical Ethics and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00